- Home
- ELDN vs NKSH Comparison
ELDN vs NKSH Comparison
Compare ELDN & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- NKSH
- Stock Information
- Founded
- ELDN 2004
- NKSH 1891
- Country
- ELDN United States
- NKSH United States
- Employees
- ELDN N/A
- NKSH N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- NKSH Major Banks
- Sector
- ELDN Health Care
- NKSH Finance
- Exchange
- ELDN Nasdaq
- NKSH Nasdaq
- Market Cap
- ELDN 178.4M
- NKSH 162.0M
- IPO Year
- ELDN N/A
- NKSH N/A
- Fundamental
- Price
- ELDN $2.89
- NKSH $26.14
- Analyst Decision
- ELDN Strong Buy
- NKSH Strong Buy
- Analyst Count
- ELDN 1
- NKSH 1
- Target Price
- ELDN $16.00
- NKSH $38.00
- AVG Volume (30 Days)
- ELDN 160.2K
- NKSH 11.1K
- Earning Date
- ELDN 05-20-2025
- NKSH 05-19-2025
- Dividend Yield
- ELDN N/A
- NKSH 5.84%
- EPS Growth
- ELDN N/A
- NKSH N/A
- EPS
- ELDN N/A
- NKSH 1.38
- Revenue
- ELDN N/A
- NKSH $46,211,000.00
- Revenue This Year
- ELDN N/A
- NKSH $1.17
- Revenue Next Year
- ELDN N/A
- NKSH $9.78
- P/E Ratio
- ELDN N/A
- NKSH $18.89
- Revenue Growth
- ELDN N/A
- NKSH 2.21
- 52 Week Low
- ELDN $2.00
- NKSH $23.75
- 52 Week High
- ELDN $5.54
- NKSH $33.37
- Technical
- Relative Strength Index (RSI)
- ELDN 40.93
- NKSH 52.22
- Support Level
- ELDN $2.85
- NKSH $25.16
- Resistance Level
- ELDN $3.51
- NKSH $26.83
- Average True Range (ATR)
- ELDN 0.27
- NKSH 0.81
- MACD
- ELDN -0.01
- NKSH 0.14
- Stochastic Oscillator
- ELDN 5.63
- NKSH 60.32
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.